Nexium and Oesophageal carcinoma - a phase IV clinical study of FDA data
Oesophageal carcinoma is found among people who take Nexium, especially for people who are male, 60+ old, have been taking the drug for 10+ years.
The phase IV clinical study analyzes which people take Nexium and have Oesophageal carcinoma. It is created by eHealthMe based on reports of 231,329 people who have side effects when taking Nexium from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
231,329 people reported to have side effects when taking Nexium.
Among them, 245 people (0.11%) have Oesophageal carcinoma.
What is Nexium?
Nexium has active ingredients of esomeprazole magnesium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 235,952 Nexium users for its effectiveness, alternative drugs and more.
What is Oesophageal carcinoma?
Oesophageal carcinoma (cancer tumour of oesophagus) is found to be associated with 734 drugs and 387 conditions by eHealthMe.
Number of Nexium and Oesophageal carcinoma reports submitted per year:
Time on Nexium when people have Oesophageal carcinoma *:
Gender of people who have Oesophageal carcinoma when taking Nexium*:
Age of people who have Oesophageal carcinoma when taking Nexium *:
Common drugs people take besides Nexium *:
Common side effects people have besides Oesophageal carcinoma *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Nexium and have Oesophageal carcinoma?Check whether Oesophageal carcinoma is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Dr. Anthony Wong, "Esomeprazole and gynaecomastia in obese adults", WHO pharmaceuticals newsletter: 2019, No. 2, 2019 Jan .
How severe was Oesophageal carcinoma and when was it recovered:
Expand to all the drugs that have ingredients of esomeprazole magnesium:
Alternative drugs to, pros and cons of Nexium:
- Nexium (235,952 reports)
Common Nexium side effects:
Browse all side effects of Nexium:a b c d e f g h i j k l m n o p q r s t u v w x y z
Oesophageal carcinoma treatments and more:
- Oesophageal carcinoma (33,075 reports)
COVID vaccines that are related to Oesophageal carcinoma:
- Oesophageal carcinoma in Moderna COVID Vaccine
- Oesophageal carcinoma in Pfizer BioNTech Covid Vaccine
- Oesophageal carcinoma in Johnson and Johnson Covid Vaccine
Common drugs associated with Oesophageal carcinoma:
All the drugs that are associated with Oesophageal carcinoma:
- Oesophageal carcinoma (734 drugs)
Common conditions associated with Oesophageal carcinoma:
- Abdominal discomfort: 3,688 reports
- Duodenal ulcer aggravated: 1,508 reports
- Gastric ulcer: 1,508 reports
- High blood pressure: 171 reports
- Indigestion: 15,098 reports
- Ms: 166 reports
- Multiple sclerosis: 175 reports
- Osteoporosis: 156 reports
- Ra: 271 reports
- Rheumatoid arthritis: 271 reports
All the conditions that are associated with Oesophageal carcinoma:
- Oesophageal carcinoma (387 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on esomeprazole magnesium (the active ingredients of Nexium) and Nexium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Prednisone and Wound Infection - 5 seconds ago
- Mobic and Combigan drug interaction - 7 seconds ago
- Revlimid and Naphazoline Hydrochloride drug interaction - 7 seconds ago
- Hytrin and Hypertrophy - 8 seconds ago
- Benadryl and Ocular Hyperaemia - 11 seconds ago
- Zerit and Weight Loss - 14 seconds ago
- Plaquenil and Foradil drug interaction - 16 seconds ago
- Clonazepam and Falmina drug interaction - 19 seconds ago
- Serzone and Blood Folate Increased - 20 seconds ago
- Levemir and Zaroxolyn drug interaction - 20 seconds ago